UBS Group »

Capstone Therapeutics Corporat shares owned by UBS Group

Quarter-by-quarter ownership of Capstone Therapeutics Corporat (CAPS) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Capstone Therapeutics Corporat

Tip: Access up to 7 years of quarterly data

All positions including Capstone Therapeutics Corporat held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capstone Therapeutics Corporat by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3k 2.5k 1.31
2025-06-30 $4.4k 2.4k 1.80
2025-03-31 $1.7k 723 2.41

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Capstone Therapeutics Corporat

Pensionmark Financial Group
Citadel Advisors
Two Sigma Securities
Two Sigma Investments
Tower Research Capital
UBS Group
Morgan Stanley

View all funds holding Capstone Therapeutics Corporat